1. Home
2. Symposiums (SBIMC)
3. Symposiums
4. 44ième symposium

44ième symposium

STATE OF THE ART ON THE PK-PD OF GLYCOPEPTIDES

• Presentation of the PK/PD workgroup. [Isabel SPRIET (UZ Leuven, Louvain)]
• Spectrum of vancomycin and susceptibility testing. [Olivier DENIS (Hôpital Erasme - ULB, Bruxelles)]
• Clinical use of glycopeptides. [Herbert SPAPEN (UZ Brussel, Bruxelles)]
• Latest issues in the PK/PD of vancomycin. [Stefaan VANDECASTEELE (AZ Sint-Jan, Bruges)]
• Therapeutic drug monitoring: news from the lab. [Pieter VERMEERSCH (UZ Leuven, Louvain)]
• Vancomycin use in special populations. [Maya HITES (Hôpital Erasme - ULB, Bruxelles)]
• Pro and con debate: vanvomycin versus linezolid. [Dirk VOGELAERS (UZ Gent, Gand) en Frédéric FRIPPIAT (CHU Liège, Liège)]